Mechanisms of failure to CCR5 inhibitors is not explained by mutation in the V3 loop, cross-resistance between CCR5 inhibitors is likely
3 July 2007. Related: Conference reports, Drug resistance.
Conference reports
Higher risk of resistance using lopinavir/r monotherapy
3 July 2007. Related: Conference reports, Drug resistance.
Macaque study shows similar protection from rectal exposure using 2-hour pre- and 24-hour post exposure prophylaxis with tenofovir plus FTC compared to daily regimen
3 July 2007. Related: Conference reports, Drug resistance.
Thirteen NNRTI mutations linked to resistance to etravirine (TMC-125)
3 July 2007. Related: Conference reports, Drug resistance.
14th Conference on Retroviruses and Opportunistic Infections, 25-28 February 2007, Los Angeles
3 July 2007. Related: Conference reports.
Protease inhibitors in pregnancy
3 July 2007. Related: Conference reports, Women's health.
Low rates of HCV treatment among eligible injection drug users
3 July 2007. Related: Conference reports, Hepatitis coinfection.
Effect of HCV and HIV on mortality among injecting drug users
3 July 2007. Related: Conference reports, Hepatitis coinfection.
HCV/HIV-co-infected IDUs are at increased risk of death from hepatitis-related death in the HAART era, compared with HCV-mono-IDUs
3 July 2007. Related: Conference reports, Hepatitis coinfection.
Long-term effectiveness of isoniazid prophylaxis on TB incidence in a cohort of IDUs
3 July 2007. Related: Conference reports, TB coinfection.
The dynamics of HCV transmission among injection drug users in St. Petersburg
3 July 2007. Related: Conference reports.
Founder effect among HIV-positive IDU in Karachi, Pakistan
3 July 2007. Related: Conference reports.
8th International Workshop on Clinical Pharmacology of HIV Therapy, April 2007, Budapest, Hungary
3 July 2007. Related: Conference reports.
Drug-drug interactions
3 July 2007. Related: Conference reports, PK and drug interactions.
Pharmacokinetic data with existing antiretrovirals
3 July 2007. Related: Conference reports.
Antiretroviral pharmacokinetics in special patient populations
3 July 2007. Related: Conference reports.
Pharmacology of investigational drugs
3 July 2007. Related: Conference reports.
14th Conference on Retroviruses and Opportunistic Infections, 25-28 February 2007, Los Angeles
5 May 2007. Related: Conference reports.
No benefit of early cessation of breastfeeding in the Zambia Exclusive Breastfeeding Study (ZEBS)
4 May 2007. Related: Conference reports, Pregnancy.
Role of infant feeding and HIV in a severe diarrhoea outbreak in Botswana
4 May 2007. Related: Conference reports, Pregnancy.
Diarrhoea in uninfected infants of HIV-positive mothers who stop breastfeeding at 6 Months
4 May 2007. Related: Conference reports, Pregnancy.
Post-weaning gastroenteritis and mortality in HIV-uninfected infants receiving antiretroviral prophylaxis
4 May 2007. Related: Conference reports, Pregnancy.
Rates of diarrhoea associated with early weaning among infants in the Kisumu breastfeeding study
4 May 2007. Related: Conference reports, Pregnancy.
Early breastfeeding cessation among infants and risk of serious gastroenteritis: findings from a perinatal prevention trial in Kampala, Uganda
4 May 2007. Related: Conference reports, Pregnancy.
Treating children in resource-limited settings
4 May 2007. Related: Conference reports, Paediatric care.
Pharmacokinetics of nevirapine, d4T, and 3TC in Zambian children treated with Pedimune (Triomune)
4 May 2007. Related: Conference reports, Paediatric care.
New PK data for protease inhibitors
4 May 2007. Related: Conference reports, Treatment access, Paediatric care, Guidelines.
Plasma concentrations of efavirenz and lopinavir in children with and without rifampicin-based TB treatment
4 May 2007. Related: Conference reports, Paediatric care, TB coinfection.
NNRTI vs PI HAART regimens for children in resource-limited settings
4 May 2007. Related: Conference reports, Paediatric care.
Predictors of infant mortality
4 May 2007. Related: Conference reports, Paediatric care.
HIV-infection in the brain, neurocognitive dysfunction and CNS drug penetration
4 May 2007. Related: Conference reports.
Selected genetics studies from CROI
4 May 2007. Related: Conference reports.
Report from genomics workshop at CROI
4 May 2007. Related: Conference reports.
5th European HIV Drug Resistance Workshop, Cascais, Portugal, 29 March 2007
4 May 2007. Related: Conference reports.
Few integrase inhibitor (INI) mutations in INI-naive people
4 May 2007. Related: Conference reports, Drug resistance.
Response to darunavir, tipranavir, or lopinavir after atazanavir failure
4 May 2007. Related: Conference reports, Drug resistance.
Upper and lower clinical cutoffs proposed for darunavir
4 May 2007. Related: Conference reports, Drug resistance.
Accuracy of Monograms Trofile assay in determining tropism and new tropism assays in development
4 May 2007. Related: Conference reports, Drug resistance.
Several genotyping systems offer hope as tropism predictors
4 May 2007. Related: Conference reports, Drug resistance.
14th Conference on Retroviruses and Opportunistic Infections, 25-28 February 2007, Los Angeles
24 April 2007. Related: Conference reports.
Raltegravir (MK-0518) phase 3 trials show successful viral suppression in multi-drug resistant patients
4 April 2007. Related: Conference reports, Antiretrovirals, Drug resistance.
Maraviroc phase 2b/3 results in treatment experienced CCR5-tropic patients
4 April 2007. Related: Conference reports, Antiretrovirals.
Phase 2 study of Gileads integrase inhibitor elvitegravir (GS-9137)
4 April 2007. Related: Conference reports, Antiretrovirals.
Phase 2b study comparing rilpivirine (TMC-278) to efavirenz in treatment-naive patients: 48-week results
4 April 2007. Related: Conference reports, Antiretrovirals.
PK results from heat-stable formulation of ritonavir
4 April 2007. Related: Conference reports, Antiretrovirals.
Use of low-dose rapamycin, a CCR5 suppressant, to increase potency of T-20 in vitro
4 April 2007. Related: Conference reports, Antiretrovirals.
Growth hormone release factor (TH9507) reduces central fat adiposity
4 April 2007. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
Further insight into risk and management of cardiovascular disease (CVD) from D:A:D cohort: no additional benefit of metabolic syndrome diagnosis; new HIV-specific CVD risk equations; increasing uptake of lipid lowering drugs but low smoking cessation
4 April 2007. Related: Conference reports, Side effects.
Pregnancy outcomes in the DART trial
4 April 2007. Related: Conference reports, Pregnancy.
12 month response to HAART in women following exposure to prevention of mother to child transmission regimens
4 April 2007. Related: Conference reports, Pregnancy.
Unexpectedly high rate of K65R mutation in patients failing first-line d4T-containing regimens in Thailand
4 April 2007. Related: Conference reports, Drug resistance.
Sexual transmission of HCV in Brighton reported in HIV positive and HIV negative MSM
4 April 2007. Related: Conference reports, Hepatitis coinfection.
Hepatitis B drug entecavir reported to have anti-HIV viral activity in three patients
4 April 2007. Related: Conference reports, Hepatitis coinfection.
High 6-month rate of PML survival with aggressive use of 5-drug T-20-based ARV regimen
4 April 2007. Related: Conference reports, Coinfections and complications.
Increased anal HPV levels in HV-positive smokers
4 April 2007. Related: Conference reports, Cancer and HIV.
Clade-B HIV-1 infection in Haiti predates global subtype-B virus
4 April 2007. Related: Conference reports.
Drug interactions and pharmacokinetic studies: CROI 2007
4 April 2007. Related: Conference reports, PK and drug interactions.
BHIVA Autumn conference, 13-14 October 2006, London
8 December 2006. Related: Conference reports.
Causes of death in the UK: results from BHIVA audit
7 December 2006. Related: Conference reports.
8th International Congress on Drug Therapy in HIV Infection, 12-16 November 2006, Glasgow
7 December 2006. Related: Conference reports.
Higher doses of ribavirin increases response rate to HCV treatment in coinfected patients: results from PRESCO study
6 December 2006. Related: Conference reports, Hepatitis coinfection.
NNRTI levels high in HCV co-Infected patients with cirrhosis
6 December 2006. Related: Conference reports, Hepatitis coinfection.
Viral load blips in children from the CHIPS cohort
6 December 2006. Related: Conference reports.
Multi-drug resistance in vertically infected children
6 December 2006. Related: Conference reports, Paediatric care, Drug resistance.
Wide disparity in switch to second-line therapy among children in CHIPS cohort
6 December 2006. Related: Conference reports, Paediatric care.